RXRX Dividend History & Analysis | N/A Yield
RXRX has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| JBIO | 280 M | 20.9% | 0.31% |
| GILD | 155,333 M | 3.14% | 7.99% |
| ABBV | 410,546 M | 2.86% | 7.80% |
| AMGN | 180,930 M | 2.83% | 4.98% |
| HLN | 44,016 M | 1.83% | 2.46% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| GRFS | 7,645 M | 127% | 60.7% |
| HLN | 44,016 M | 51.0% | 100% |
| AMGN | 180,930 M | 8.90% | 100% |
| ABBV | 410,546 M | 7.06% | 100% |
| GILD | 155,333 M | 3.16% | 100% |
Similar Stocks with Attractive Dividends - Compare RXRX Dividends with its Peer-Group
2.86% Yield
2.83% Yield
3.14% Yield
1.83% Yield
RXRX Dividend History: as of November 2025
No dividends paid yet.RXRX Dividend FAQ
Recursion Pharmaceuticals (NASDAQ:RXRX) is a clinical-stage biotech that combines high-throughput biology, chemistry, automation, and AI-driven data science to “industrialize” drug discovery. Its lead pipeline includes REC-994 (Phase 2 for cerebral cavernous malformation), REC-2282 (Phase 2/3 for neurofibromatosis type 2), REC-4881 (Phase 1b/2 for familial adenomatous polyposis and Phase 2 for AXIN1/APC-mutant cancers), REC-3964 (Phase 1 for Clostridioides difficile infection), and a preclinical RBM39 program targeting HR-proficient ovarian cancer. The firm maintains research collaborations with Bayer, Roche & Genentech, Takeda, the University of Utah, and the Ohio State Innovation Foundation.
What is the Dividend Yield of RXRX?
As of November 2025, RXRX`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 3.85.Does RXRX pay a dividend?
As of November 2025 RXRX does not pay a dividend.How often does RXRX pay dividends?
Over the last 12 months, RXRX has issued dividend payments.Will RXRX pay dividends in 2025?
The next Ex-Dividend date for Recursion Pharmaceuticals (RXRX) is currently unknown.What is the next Ex-Dividend Date for RXRX?
The next Ex-Dividend date for Recursion Pharmaceuticals (RXRX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of RXRX?
RXRX's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of RXRX?
RXRX's 5-Year Yield on Cost is -%. If you bought RXRX's shares at 31.30 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of RXRX?
RXRX Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does RXRX have a good Dividend Yield?
RXRX`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of RXRX?
The Dividend Payout Ratio of RXRX is unknown.What is the Dividend Rating of RXRX?
RXRX`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-11-17 02:02